GlassScriptPhysician profile
Hani M Annabi
NPI 1700819927
$3,479.73
in general payments reported to CMS, 2019-2025
23 companies · $428 in 2025
The $428 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $522 · 2020: $567 · 2021: $509 · 2022: $496 · 2023: $448 · 2024: $510 · 2025: $428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,187 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,187.26 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $2,613.19 | 2019-2025 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $179.18 | 2024-2025 | Gemtesa |
| Pfizer INC. | $95.62 | 2020-2022 | |
| Allergan, INC. | $78.19 | 2020 | |
| Convatec INC. | $68.21 | 2024 | |
| Axonics, INC. | $48.86 | 2023 | Bulkamid |
| Avita Medical Americas, LLC | $46.54 | 2024 | |
| Merck Sharp & Dohme LLC | $39.95 | 2020 | |
| Janssen Biotech, INC. | $35.59 | 2025 | Erleada |
| Abbvie INC. | $34.67 | 2024-2025 | |
| Horizon Therapeutics Plc | $26.11 | 2022 | |
| Olympus America INC. | $23.11 | 2025 | Itind System |
| Tolmar, INC. | $22.28 | 2023 | |
| Procept Biorobotics Corporation | $21.06 | 2021 | |
| Daiichi Sankyo INC. | $20.00 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $18.61 | 2020 | |
| Verity Pharmaceuticals INC. | $18.11 | 2025 | Tlando |
| Medtronic Vascular, INC. | $17.66 | 2020 | |
| Tolmar Pharmaceuticals, INC. | $16.94 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $16.41 | 2024 | Eliquis |
| Myovant Sciences INC. | $13.98 | 2021 | |
| Blue Earth Diagnostics | $13.30 | 2021 | |
| Novartis Pharmaceuticals Corporation | $12.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hani Annabi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.